These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 20675857

  • 1. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT, Houghton K, Bond M, Senger C, Tucker LB.
    J Rheumatol; 2010 Aug 01; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract] [Full Text] [Related]

  • 2. ["Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab].
    Petschner F, Walker UA, Schmitt-Gräff A, Uhl M, Peter HH.
    Dtsch Med Wochenschr; 2001 Sep 14; 126(37):998-1001. PubMed ID: 11555773
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of recurrent lupus enteritis with rituximab.
    Oh JS, Kim YG, Lee SG, Lee CK, Yoo B.
    Lupus; 2010 Feb 14; 19(2):220-2. PubMed ID: 19880555
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM, Lionberger J, Gopal AK, Sabath DE, Loeb K.
    Am J Hematol; 2007 Dec 14; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract] [Full Text] [Related]

  • 5. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
    Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M, Graillet D, Gonzalez L, Rojas-Rodriguez J, Pineda-Almazana A, Zamudio-Huerta L, Lopez-Colombo A.
    Lupus; 2010 Feb 14; 19(2):213-9. PubMed ID: 19965944
    [Abstract] [Full Text] [Related]

  • 6. Lupus cystitis in association with severe gastrointestinal manifestations in an adolescent.
    Dancey P, Constantin E, Duffy CM, Scuccimarri R.
    J Rheumatol; 2005 Jan 14; 32(1):178-80. PubMed ID: 15630745
    [Abstract] [Full Text] [Related]

  • 7. Six refractory lupus patients treated with rituximab: a case series.
    Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J.
    Arthritis Rheum; 2007 Apr 15; 57(3):538-42. PubMed ID: 17394185
    [No Abstract] [Full Text] [Related]

  • 8. [Rosai-Dorfman disease revealed by renal failure: case report].
    Laboudi A, Haouazine N, Benabdallah L, Arzouk N, Cherradi N, Rhou H, Benamar L, Ezaitouni F, Ouzeddoun N, Hamani Z, Balafrej L.
    Nephrologie; 2001 Apr 15; 22(2):53-6. PubMed ID: 11385902
    [Abstract] [Full Text] [Related]

  • 9. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
    Kittaka K, Dobashi H, Baba N, Iseki K, Kameda T, Susaki K, Kitanaka A, Kubota Y, Ishida T.
    Scand J Rheumatol; 2008 Apr 15; 37(5):390-3. PubMed ID: 18609263
    [Abstract] [Full Text] [Related]

  • 10. [Biological treatment of rare inflammatory rheumatic diseases].
    Baslund B.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2150-2. PubMed ID: 18565301
    [Abstract] [Full Text] [Related]

  • 11. Rosai-Dorfman disease in a patient with systemic lupus erythematosus.
    Kaur PP, Birbe RC, DeHoratius RJ.
    J Rheumatol; 2005 May 09; 32(5):951-3. PubMed ID: 15868635
    [Abstract] [Full Text] [Related]

  • 12. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P.
    Med Klin (Munich); 2003 Jun 15; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract] [Full Text] [Related]

  • 13. [Allergo-immunology. Clinical immunology].
    Chizzolini C.
    Rev Med Suisse; 2012 Jan 11; 8(323):11-3. PubMed ID: 22303732
    [Abstract] [Full Text] [Related]

  • 14. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
    Lim SW, Gillis D, Smith W, Hissaria P, Greville H, Peh CA.
    Intern Med J; 2006 Apr 11; 36(4):260-2. PubMed ID: 16640745
    [Abstract] [Full Text] [Related]

  • 15. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
    Lui NL, Thumboo J, Fong KY.
    Int J Rheum Dis; 2009 Dec 11; 12(4):366-9. PubMed ID: 20374378
    [Abstract] [Full Text] [Related]

  • 16. Rituximab therapy for childhood-onset systemic lupus erythematosus.
    Willems M, Haddad E, Niaudet P, Koné-Paut I, Bensman A, Cochat P, Deschênes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B, French Pediatric-Onset SLE Study Group.
    J Pediatr; 2006 May 11; 148(5):623-627. PubMed ID: 16737873
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary manifestations revealing Rosai-Dorfman disease.
    Goupil de Bouillé J, de Muret A, Diot E, Dumont P, Plantier L, Diot P, Marchand-Adam S.
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep 14; 32(3):275-7. PubMed ID: 26422575
    [Abstract] [Full Text] [Related]

  • 18. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X, Club Rheumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2005 Jun 14; 64(6):913-20. PubMed ID: 15550531
    [Abstract] [Full Text] [Related]

  • 19. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Jun 14; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 20. Rituximab in systemic lupus erythematosus.
    Abud-Mendoza C, González-Amaro R.
    Lupus; 2010 Apr 14; 19(5):658. PubMed ID: 19900978
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.